Search by Drug Name or NDC

    NDC 72205-0079-30 PREGABALIN 330 mg/1 Details

    PREGABALIN 330 mg/1

    PREGABALIN is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novadoz Pharmaceuticals LLC. The primary component is PREGABALIN.

    Product Information

    NDC 72205-0079
    Product ID 72205-079_f6aa5977-97c8-4a56-8e35-d9ab5cc24369
    Associated GPIs 62540060007540
    GCN Sequence Number 077836
    GCN Sequence Number Description pregabalin TAB ER 24H 330 MG ORAL
    HIC3 H5B
    HIC3 Description NEUROPATHIC AGENTS
    GCN 43988
    HICL Sequence Number 026470
    HICL Sequence Number Description PREGABALIN
    Brand/Generic Generic
    Proprietary Name PREGABALIN
    Proprietary Name Suffix n/a
    Non-Proprietary Name PREGABALIN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 330
    Active Ingredient Units mg/1
    Substance Name PREGABALIN
    Labeler Name Novadoz Pharmaceuticals LLC
    Pharmaceutical Class n/a
    DEA Schedule CV
    Marketing Category ANDA
    Application Number ANDA213226
    Listing Certified Through 2024-12-31

    Package

    NDC 72205-0079-30 (72205007930)

    NDC Package Code 72205-079-30
    Billing NDC 72205007930
    Package 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72205-079-30)
    Marketing Start Date 2021-04-13
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL f6aa5977-97c8-4a56-8e35-d9ab5cc24369 Details

    Revised: 12/2020